Get the Stockscreener App
3.13
2.62%
0.08
Cumberland Pharmaceuticals Inc stock is traded at $3.13, with a volume of 21,191.
It is up +2.62% in the last 24 hours and down -20.15% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
See More
Previous Close:
$3.05
Open:
$2.94
24h Volume:
21,191
Relative Volume:
0.12
Market Cap:
$46.81M
Revenue:
$44.52M
Net Income/Loss:
$-2.86M
P/E Ratio:
-16.37
EPS:
-0.1912
Net Cash Flow:
$4.75M
1W Performance:
+3.99%
1M Performance:
-20.15%
6M Performance:
+2.28%
1Y Performance:
-28.86%
1-Day Range:
$2.94
$3.19
1-Week Range:
$2.69
$3.20
52-Week Range:
$1.85
$6.265
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.13 | 46.81M | 44.52M | -2.86M | 4.75M | -0.1912 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
CPIX SEC FilingsCumberland Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Director at Cumberland Pharmaceuticals (CPIX) receives 1,800-share stock grant - Stock Titan
Cumberland Pharmaceuticals (CPIX) director receives 1,800-share stock grant - Stock Titan
Cumberland Pharmaceuticals (CPIX) director granted 1,800 shares in Form 4 filing - Stock Titan
[Form 4] CUMBERLAND PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
Cumberland (CPIX) director Caroline Young receives 1,800-share stock grant - Stock Titan
Cumberland (CPIX) VP awarded 3,000 stock options at $2.80 strike - Stock Titan
Cumberland (CPIX) VP awarded options to buy 3,000 shares at $2.80 - Stock Titan
Cumberland Pharmaceuticals (CPIX) CFO granted 3,000 stock options - Stock Titan
Cumberland Pharmaceuticals (CPIX) CEO granted 100,000 stock options - Stock Titan
Retail Trends: What makes Cumberland Pharmaceuticals Inc stock attractive todayIndex Update & Precise Swing Trade Alerts - baoquankhu1.vn
Cumberland (NASDAQ: CPIX) CEO A.J. Kazimi reports routine tax-withholding share disposition - Stock Titan
Cumberland targets double-digit revenue growth in 2026 as Talicia and Vibativ fuel expansion - MSN
New site spotlights chemo nausea patch that helps for five days - Stock Titan
Cumberland Pharmaceuticals Stock Rating Upgraded - National Today
Aug Macro: What is the dividend yield of Cumberland Pharmaceuticals Inc2026 Summary & Community Verified Trade Signals - baoquankhu1.vn
[ARS] CUMBERLAND PHARMACEUTICALS INC SEC Filing - Stock Titan
Trend Report: Can Cumberland Pharmaceuticals Inc beat the S P 500Trade Exit Summary & High Conviction Buy Zone Picks - baoquankhu1.vn
Dilated Cardiomyopathy Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bristol Myers Squibb, Berlin Cures, Cumberland Pharma, Vericel Corp, Corimmun GmbH, Pfizer, Constant Therapeut - Barchart.com
Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales - The Globe and Mail
Cumberland Pharmaceuticals (NASDAQ: CPIX) details 2026 director, pay and auditor votes - Stock Titan
Cumberland Pharmaceuticals Inc. Business Overview, Product Portfolio, Growth Strategy, and International Partnerships 2025 - Minichart
Cumberland Pharmaceuticals 2025 10-K — Revenue $44.5M, Net loss $2.9M - TradingView
Swing Trade: What is the dividend yield of Cumberland Pharmaceuticals IncPortfolio Risk Summary & Low Risk High Reward Trade Ideas - baoquankhu1.vn
How resilient is Cumberland Pharmaceuticals Inc. stock in market downturns2026 Rallies & Low Volatility Stock Recommendations - Naître et grandir
Risk Recap: Will Cumberland Pharmaceuticals Inc announce a stock splitJuly 2025 Catalysts & Short-Term High Return Ideas - baoquankhu1.vn
Aug Highlights: Can Cumberland Pharmaceuticals Inc reach all time highs this year - baoquankhu1.vn
Momentum Shift: Is Cumberland Pharmaceuticals Inc in a bullish channelTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Pale Fire Capital Bets Big on Healthcare With a 2.07 Million Share Baxter International (BAX) Investment - AOL.com
1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth - AOL.com
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance - AOL.com
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com
147M H. pylori patients set stage for new stomach infection drugs - Stock Titan
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection - AOL.com
CPIX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cumberland Pharmaceuticals Reports 31% Q4 2025 Revenue Growth, Expands Internationally, and Achieves Key Clinical and Financial Milestones - Minichart
Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com
Cumberland: Fourth Quarter Financial Results Overview - Bitget
Earnings call transcript: Cumberland Pharmaceuticals Q4 2025 sees revenue surge - Investing.com
Cumberland Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Cumberland: Q4 Earnings Snapshot - GreenevilleSun.com
Cumberland Pharmaceuticals 2025 revenue rises - TradingView
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH - PR Newswire
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale - AOL.com
Joint U.S. Commercialization of RedHill's Talicia® Commences - marketscreener.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA® - weeklyvoice.com
Cumberland Pharma schedules Mar. 3 call on 2025 results and company update - Stock Titan
Volume Report: Why is Cumberland Pharmaceuticals Inc stock going upWeekly Trend Recap & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge - AOL.com
Merger Talk: Can Cumberland Pharmaceuticals Inc reach all time highs this yearPrice Action & Weekly Top Performers Watchlists - baoquankhu1.vn
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):